NL-OMON27886尚未招募不适用
ptake and biodistribution of 89Zirconium-labeled ipilimumab in ipilimumab treated patients with metastatic melanoma
VU University Medical Center0 个研究点目标入组 29 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 29
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Advanced/metastatic melanoma.
- •- Scheduled for treatment with ipilimumab.
排除标准
- •- Previous exposure to ipilimumab.
- •- Pregnant or breast-feeding subjects.
研究者
相似试验
进行中（未招募）
1 期
ptake of 89Zr-labeled ipilimumab measured with PET-scan in patients who are treated with ipilimumabMedDRA version: 21.1Level: PTClassification code 10025671Term: Malignant melanoma stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10025670Term: Malignant melanoma stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Advanced melanomaEUCTR2012-003616-31-NLVU medical center24
招募中
不适用
ptake and biodistribution of 89Zirconium-labeled ipilimumab in ipilimumab treated patients with metastatic melanomamelanoma10040900NL-OMON53144Vrije Universiteit Medisch Centrum22
已完成
不适用
A Phase I Study to Assess Biodistribution of 89Zr-CB307 in PSMA+ and PSMA-Tumour LesionsNL-OMON51775Cresendo Biologics Ltd12
招募中
1 期
Safety, tolerability, and biodistribution of [89Zr]Zr-DFO-APAC (Phase 0) in subjects with peripheral arterial occlusive disease / critical limb ischemia (PAOD/CLI) and healthy volunteers – an open label PET study (CHASE-study)Critical limb ischemia, Peripheral arterial occlusive diseaseMedDRA version: 21.1Level: LLTClassification code: 10058072Term: Critical limb ischaemia Class: 10047065MedDRA version: 21.1Level: PTClassification code: 10062585Term: Peripheral arterial occlusive disease Class: 100000004866CTIS2023-505287-11-01Aplagon Oy10
终止
1 期
Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid TumoursAdvanced Solid TumorNCT05638334Institut de Recherches Internationales Servier3